Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (68)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (2)
Immunology (32)
Inflammation and immunity (53)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info@vib.be
Recent press releases
New VIB research concludes that antibiotic tolerance in bacteria leads to genetic resistance
22 January 2019
A study conducted at the VIB-KU Leuven Center for Microbiology supports the theory that in bacteria, the strategy of generating ‘sleeping’ persister cells to survive antibiotic treatment drives the evolution of highly resistant strains.
Leuven experts push the boundaries of 3D microscopy
16 January 2019
Sebastian Munck and Natalia Gunko, two expert technologists at VIB-KU Leuven, report new imaging protocols that will advance neuroscience and (bio)imaging in general.
Europe looks to cells for a healthier future
15 January 2019
The body’s cells are constantly changing. But which of these changes are healthy developments and which lead to serious diseases? This is what LifeTime, a transnational and interdisciplinary initiative of leading European researchers, wants to figure out.
CRISPR field trial research to be continued in 2019
14 January 2019
Since 2017, VIB performs field trials with maize plants in which small genetic changes have been introduced using the precision breeding technique CRISPR.
The best of the best highly cited researchers at VIB
13 January 2019
We are very proud of the fact that the number of ‘highly cited researchers’ from VIB increases every year, with a total of 18 VIB scientists currently listed by Clarivate Analytics – formerly the IP and science business of Thomson Reuters.
Ten Million Euro for Access to European Proteomics Facilities
12 January 2019
The European Union has awarded 10 million euro to a consortium of eighteen European research groups in the field of mass spectrometry based proteomics research throughout Europe. Three VIB-UGent groups are actively involved in this project
Unraveling the molecular mysteries of the brain: Joris de Wit’s lab walks the cutting edge of neuroscience
11 January 2019
New technologies and bright minds at VIB are making important advances in our understanding of our brains. Researchers in the lab of Joris de Wit, are first authors on papers published in Neuron that shed new light on the brain’s molecular mysteries.
Researchers answer decades-old question about protein found in Alzheimer’s brain plaques
10 January 2019
A team of scientists at VIB and KU Leuven led by professors Joris de Wit and Bart De Strooper has now uncovered that this amyloid precursor protein modulates neuronal signal transmission through binding to a specific receptor.
Unconventional immune cells trigger disturbed cytokine production in human spondyloarthritis
10 January 2019
Koen Venken and Dirk Elewaut from the VIB-UGent Inflammation Research Center now report in Nature Communications that rare populations of unconventional T cells may account for this intriguing clinical observation.
Quickscan - End of 2018
8 January 2019
How do carrier proteins transport ADP and ATP in and out of mitochondria?
8 January 2019
Scientists at the MRC-MBU in Cambridge, UK have discovered how a key transport protein, called the mitochondrial ADP/ATP carrier, transports adenosine triphosphate (ATP), the chemical fuel of the cell.
Megabodies: a new tool for innovative applications in research and drug discovery
3 January 2019
The Jan Steyaert lab at the VIB-VUB Center for Structural Biology developed an innovative plug and play technology to rigidly graft functional Nanobodies® on several scaffolds with diverse properties to build Megabodies.
New mouse model reminiscent of Leigh syndrome sheds light on mechanisms of neurodegeneration
2 January 2019
Leuven researchers led by professor Bart De Strooper (VIB-KU Leuven) have identified a new role for PARL, a protein that has been linked to Parkinson’s disease.
Three new VIB studies reveal key role of metabolism in blood vessel health
28 December 2018
The lab of Peter Carmeliet (VIB-KU Leuven Center for Cancer Biology) zooms in on the growth of blood vessels in both healthy and pathological contexts, regularly making new discoveries that advance the field.
Leuven scientists tackle one immune disease after the other
20 December 2018
In two recent studies, the same team of scientists has uncovered the mechanisms underlying two distinct immunological disorders affecting both children and adults. Stephanie Humblet-Baron (VIB-KU Leuven) was the researcher at the helm of both projects.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
Next»
Page Content Zone 2
Page Content Zone 3